drugset / Trial / NCT02764892
A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease
NaSingle-groupOpen-labelBasic science
Summary
The main purpose of the study is to identify the best dose of V81444 to use in future trials in patients with Parkinson's disease. The study will also explore the effects of V81444 on brain activity and blood flow with tests of mental ability ("cognitive function tests"). It will also check how safe V81444 is and how well it is tolerated after dosing.
Timeline
- Start
- 2012-08
- Primary completion
- 2012-11
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ciforadenant | Small molecule | 50 mg | Oral |
| Subject | Ciforadenant | Small molecule | 100 mg | Oral |
| Subject | Ciforadenant | Small molecule | 250 mg | Oral |